Abbott Settles TriCor Patent Spat With Teva
Abbott Laboratories has reached a license agreement with Teva Pharmaceuticals USA Inc., resolving a patent dispute between the companies over Teva's planned generic version of the cholesterol drug TriCor....To view the full article, register now.
Already a subscriber? Click here to view full article